Session Details

Prevention: are biomarkers worth their money?
31 Aug 08:30 - 10:00 Secondary cardiovascular prevention: interventions and outcomes Abstract Session Helsinki - Zone D
Chairpersons: Miran KENDA (Ljubljana, SI), Massimo VOLPE (Rome, IT)

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:305182High-risk single-nucleotide polymorphisms (SNPs) and genetic score on recurrent cardiovascular events following ischaemic heart diseaseMaria Grazia ANDREASSI (Massa, IT)
08:455183Increasing levels of C-reactive protein are associated with accelerated progression of coronary atherosclerosisKiyoko UNO (Cleveland, US)
09:005184High-sensitivity troponin T predicts recurrent cardiovascular disease events in stable coronary heart disease patients: 8-year follow-up of the KAROLA studyWolfgang KOENIG (Ulm, DE)
09:155185The plasma level of B-type natriuretic peptide is a useful predictor of cardiac events for out-clinic patients with asymptomatic heart failure who are in a stable conditionMinako YAMAOKA-TOJO (Sagamihara, JP)
09:305186Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with dual antiplatelet therapySvein SOLHEIM (Oslo, NO)
09:455187Increasing circulating concentration of all HDL particle subclasses in hyper-responders: insights from the ASSERT study to apolipoprotein A-I inductionStephen James NICHOLLS (Adelaide, AU)

Who we are

What we do

How we work

More ESC